Cleared Traditional

K862064 - ENTRAVISION EP-500 I/A ECCO PACK

K862064 is an FDA 510(k) clearance for ENTRAVISION EP-500 I/A ECCO PACK, manufactured by Entravision, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 20-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1986
Decision
20d
Days
Class 2
Risk

K862064 is an FDA 510(k) clearance for the ENTRAVISION EP-500 I/A ECCO PACK. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Entravision, Inc. (Lenoir, US). The FDA issued a Cleared decision on June 19, 1986 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K862064

510(k) Number K862064 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 1986
Decision Date June 19, 1986
Days to Decision 20 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 110d · This submission: 20d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K862064.
MODEL A-8000 ULTRASONIC HANDPIECE CORD
K862777 · Advanced Medical Technology, Inc. · Aug 1986
PHACOEMULSIFICATION ULTRASONIC FRAGMENT SYSTEM
K862021 · Ultramed, Inc. · Jun 1986
ENTRAVISION MODECO II I/A MACHINE & I/A HANDPIECE
K862063 · Entravision, Inc. · Jun 1986
KANSAS I/A SYSTEM & KANSAS I/A & VITRECTROMY SYST.
K860956 · Medical Corp. of America · Jun 1986
DISPOSABLE ACCESSORIES FOR I/A SYS. & VITEOUS CUT.
K860957 · Medical Corp. of America · Jun 1986
SITE DISPOSABLE CASSETTE
K860989 · Microsurgical Systems, Inc. · May 1986